Three University of Barcelona spin-offs receive funding from Women TechEU

,
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i Gimpera

THREE UNIVERSITY OF BARCELONA SPIN-OFFS LED BY WOMEN WILL RECEIVE FUNDING AS PART OF THE WOMEN TechEU PILOT CALL.

NIMBLE Diagnostics, Gate2Brain and ColorSensing, spin-offs from the Universitat de Barcelona , ​​have been selected as part of the Women TechEU pilot call, a new European Union program that supports emerging Deep Tech companies led by women.

The three UB spin-offs will this year receive an individual grant of 75,000 euros to support the first steps of their innovation process and the growth of their company. In addition, they will be offered advice under the Women’s Leadership Program of the European Innovation Council and SMEs Executive Agency (EISMEA) and dedicated networking opportunities across the EU.

Source: http://www.fbg.ub.edu/actualitat/tres-spin-off-de-la-ub-liderades-per-dones-rebran-financament-en-el-marc-de-la-convocatoria-pilot-women-techeu/

/by
You might also like
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production Models
Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelonaGate2Brain attends the 1st edition of the University of Barcelona spin-offs “Cockroaches vs Unicorns”
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoceGate2Brain opens one million euro bridge round for preclinical trials
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
medicines beyond barriersG2BMedicines beyond barriers
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del TreballThe innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Sometimes the impossible only comes laterTHIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN